List of Atorvaliq drug patents
Atorvaliq is owned by Cmp Dev Llc.
Atorvaliq contains Atorvastatin Calcium.
Atorvaliq has a total of 1 drug patent out of which 0 drug patents have expired.
Atorvaliq was authorised for market use on 01 February, 2023.
Atorvaliq is available in suspension;oral dosage forms.
The generics of Atorvaliq are possible to be released after 07 June, 2037.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11369567 | CMP DEV LLC | Aqueous suspension suitable for oral administration |
Jun, 2037
(14 years from now) | |
Do you want to check out ATORVALIQ patents from before 2022?
Drugs and Companies using ATORVASTATIN CALCIUM ingredient
Market Authorisation Date: 01 February, 2023
Treatment: NA
Dosage: SUSPENSION;ORAL
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic